ISO 9001:2015 Certified
Live Customer Support
4.5/5 on Trustpilot
100% Quality Guarantee

Obinutuzumab Biosimilar - Anti-CD20 Antibody - Low endotoxin, Azide free (A323615)

Recombinant humanized monoclonal antibody to CD20 for ELISA, FACS, Functional Assay and In Vivo.

Shipping Information

$40
Dispatched from St. Louis, MO.
Lead Time: 12-18 business days.
Name
Obinutuzumab Biosimilar - Anti-CD20 Antibody - Low endotoxin, Azide free
Description
Recombinant humanized monoclonal antibody to CD20.
Applications
ELISA, FACS, Functional Assay, In Vivo
Reactivity
Human, Cynomolgus Macaque
Host
Humanized
Clonality
Monoclonal
Isotype
IgG1
Light Chains
kappa
Conjugate

Unconjugated

Purification
Protein A affinity chromatography.
Concentration
Reconstitution dependent.
Molecular Weight
This antibody has a predicted MW of 146.32 kDa.
Purity
> 90% (by SDS-PAGE and SEC-HPLC).
Product Form
Lyophilized
Reconstitution
Reconstitute with 100µl of sterile double-distilled water to bring antibody to 1mg/ml concentration. Gently shake to solubilize completely. Do not vortex!
Formulation
Lyophilized from 25mM Histadine, pH 6.2, with 8% Sucrose and 0.01% Tween80.
Storage
Shipped at 4°C. Lyophilized: Store at -20°C to -80°C. Reconstituted: Aliquot and store at -80°C. Product is stable for one year. Avoid freeze/thaw cycles.
Synonyms
B-lymphocyte antigen CD20, B-lymphocyte surface antigen B1, Bp35, Leukocyte surface antigen Leu-16, Membrane-spanning 4-domains subfamily A member 1, MS4A1
Disclaimer
This product is for research use only. It is not intended for diagnostic or therapeutic use.
Publishing research using Obinutuzumab Biosimilar - Anti-CD20 Antibody - Low endotoxin, Azide free (A323615)? Please let us know so that we can list the citation on this page.

Alternative products to Obinutuzumab Biosimilar - Anti-CD20 Antibody - Low endotoxin, Azide free (A323615)

Proteins predicted to interact with CD20

Predicted protein interactions based upon String database. Revelancy score correlates with probability of interaction.
97.6% Relevancy Score
93.5% Relevancy Score
92.8% Relevancy Score
88.9% Relevancy Score
87.9% Relevancy Score
87.5% Relevancy Score
83.7% Relevancy Score
82.6% Relevancy Score
82% Relevancy Score